The Korea Medical Institute said Tuesday it has signed a memorandum of understanding with US-based Guardant Health to collaborate on liquid biopsy-based precision cancer screening.

The agreement was signed March 5 at the KMI F

πŸ“°

Continue Reading on The Korea Herald

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article β†’